A detailed history of Gladstone Institutional Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 664 shares of VRTX stock, worth $280,208. This represents 0.02% of its overall portfolio holdings.

Number of Shares
664
Previous 1,313 49.43%
Holding current value
$280,208
Previous $615,000 49.92%
% of portfolio
0.02%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$460.0 - $505.78 $298,540 - $328,251
-649 Reduced 49.43%
664 $308,000
Q2 2024

Aug 02, 2024

SELL
$392.81 - $485.53 $957,277 - $1.18 Million
-2,437 Reduced 64.99%
1,313 $615,000
Q1 2024

May 14, 2024

SELL
$407.69 - $446.08 $1.97 Million - $2.16 Million
-4,835 Reduced 56.32%
3,750 $1.57 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $509,012 - $609,449
1,484 Added 20.9%
8,585 $3.49 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $85,559 - $91,702
253 Added 3.69%
7,101 $2.47 Million
Q2 2023

Aug 10, 2023

BUY
$314.42 - $351.91 $72,631 - $81,291
231 Added 3.49%
6,848 $2.41 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $827,598 - $944,098
-2,922 Reduced 30.63%
6,617 $2.08 Million
Q4 2022

Feb 01, 2023

BUY
$285.76 - $321.48 $2.73 Million - $3.07 Million
9,539 New
9,539 $2.75 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $108B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.